GENERATE BIOMEDICINES INC

GENBNASDAQ

🏆 #1717 by market capEarnings Nov 5US Equity

$345.97▼ $5.54 (−1.60%)

Simulated price

1h—

24h▼ 1.6%

7d—

14d—

30d—

1y—

🏦Market Cap

$1.83B

Small Cap

📈Revenue Growth (YoY)

+55.9%

High Growth

📊Gross Margin

75.8%

High

💵FCF Margin

-1056.6%

Thin

⚖️P/S Ratio

135.1x

Expensive

Otter Score

50

Weak

📊

Analyst Ratings

Price

$345.97

Total

2

Raised

0

Lowered

0

Avg PT

$23.50

H / L

$25 / $22

Institution	Action	Rating	Date
Morgan Stanley	Reiterated	Overweight	2026-05-14
HC Wainwright & Co.	Reiterated	Buy	2026-05-08

One row per institution, most recent rating